Accexible 

Speech biomarkers for screening and monitoring of mental health conditions.

OWNER

Carla Zaldua (See Profile)


Sector

Digital Health

Stage

Development, market readiness, clinical trial

Country

spain


Accexible's vocal biomarkers have an accuracy of more than 90% for the detection of mental health conditions.

Accexible reduces the time of diagnosis, is objective and is scalable.

In use by 40+neurologists and psychiatrists and 4500 patients in Spain, UK, Colombia and USA. Accexible's platform has received the CE Marking medical device

Status

Pending

IP Type

PCT

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

The method for early detection and monitoring of mild cognitive impairment and dementia through speech analysis.

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 21 September 2022

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar